| scholarly article | Q13442814 |
| P50 | author | Philippe Grandjean | Q16145198 |
| Xianming Zhang | Q48356720 | ||
| Elsie M. Sunderland | Q41068181 | ||
| P2093 | author name string | Qi Sun | |
| Francine Laden | |||
| Jaime E Hart | |||
| Leo W Y Yeung | |||
| Jahred Liddie | |||
| Xindi C Hu | |||
| Andrea K Tokranov | |||
| P2860 | cites work | Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources | Q24626351 |
| Occurrence of perfluoroalkyl carboxylates and sulfonates in drinking water utilities and related waters from the United States | Q43226218 | ||
| Subsurface transport potential of perfluoroalkyl acids at aqueous film-forming foam (AFFF)-impacted sites | Q43680669 | ||
| Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length | Q44260358 | ||
| Levels of perfluorochemicals in water samples from Catalonia, Spain: is drinking water a significant contribution to human exposure? | Q44461419 | ||
| Characterisation of human exposure pathways to perfluorinated compounds--comparing exposure estimates with biomarkers of exposure | Q45357022 | ||
| A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring | Q46233393 | ||
| Analysis of fluorotelomer alcohols, fluorotelomer acids, and short- and long-chain perfluorinated acids in water and biota | Q46761004 | ||
| Simple intake and pharmacokinetic modeling to characterize exposure of Americans to perfluoroctanoic acid, PFOA. | Q46824097 | ||
| Identification and quantification of linear and branched isomers of perfluorooctanoic and perfluorooctane sulfonic acids in contaminated groundwater in the veneto region | Q47227119 | ||
| Determination of blood pressure percentiles in normal-weight children: some methodological issues | Q47250239 | ||
| Key scientific issues in developing drinking water guidelines for perfluoroalkyl acids: Contaminants of emerging concern | Q47276625 | ||
| Influence of contaminated drinking water on perfluoroalkyl acid levels in human serum--A case study from Uppsala, Sweden | Q47728833 | ||
| A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)? | Q48208982 | ||
| Identification of Novel Perfluoroalkyl Ether Carboxylic Acids (PFECAs) and Sulfonic Acids (PFESAs) in Natural Waters Using Accurate Mass Time-of-Flight Mass Spectrometry (TOFMS). | Q48944213 | ||
| Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study | Q50041743 | ||
| Comparative pharmacokinetics of perfluorohexanesulfonate (PFHxS) in rats, mice, and monkeys. | Q51424043 | ||
| Comparing measured and modelled PFOS concentrations in a UK freshwater catchment and estimating emission rates. | Q51440837 | ||
| Impacts of daily intakes on the isomeric profiles of perfluoroalkyl substances (PFASs) in human serum. | Q51541816 | ||
| Contribution of Direct and Indirect Exposure to Human Serum Concentrations of Perfluorooctanoic Acid in an Occupationally Exposed Group of Ski Waxers. | Q53080615 | ||
| Shifting Global Exposures to Poly- and Perfluoroalkyl Substances (PFASs) Evident in Longitudinal Birth Cohorts from a Seafood-Consuming Population | Q56795458 | ||
| Zürich Statement on Future Actions on Per- and Polyfluoroalkyl Substances (PFASs) | Q57102714 | ||
| Determination of trace levels of total fluorine in water using combustion ion chromatography for fluorine: a mass balance approach to determine individual perfluorinated chemicals in water | Q79577415 | ||
| Simultaneous determination of perfluoroalkyl phosphonates, carboxylates, and sulfonates in drinking water | Q84596095 | ||
| Comment on "The environmental photolysis of perfluorooctanesulfonate, perfluorooctanoate, and related fluorochemicals" | Q87710618 | ||
| Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modeling | Q88107216 | ||
| A transgenerational toxicokinetic model and its use in derivation of Minnesota PFOA water guidance | Q90989869 | ||
| A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects | Q93336503 | ||
| Biomonitoring for perfluorochemicals in a Minnesota community with known drinking water contamination | Q95622548 | ||
| Source Attribution of Poly- and Perfluoroalkyl Substances (PFASs) in Surface Waters from Rhode Island and the New York Metropolitan Area | Q28816917 | ||
| Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). | Q31109567 | ||
| A first global production, emission, and environmental inventory for perfluorooctane sulfonate | Q33411870 | ||
| An assessment of the exposure of Americans to perfluorooctane sulfonate: a comparison of estimated intake with values inferred from NHANES data | Q33530459 | ||
| The Madrid Statement on Poly- and Perfluoroalkyl Substances (PFASs) | Q34474613 | ||
| Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community | Q34478458 | ||
| Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility | Q34478572 | ||
| Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers | Q34680365 | ||
| Estimating consumer exposure to PFOS and PFOA. | Q34770851 | ||
| Tracking the pathways of human exposure to perfluorocarboxylates. | Q35001255 | ||
| Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. | Q36095017 | ||
| Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010 | Q36456151 | ||
| Using Monte Carlo simulation to assess variability and uncertainty of tobacco consumption in a city by sewage epidemiology | Q36602905 | ||
| Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water | Q36633077 | ||
| Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children | Q36814940 | ||
| Detection of Poly- and Perfluoroalkyl Substances (PFASs) in U.S. Drinking Water Linked to Industrial Sites, Military Fire Training Areas, and Wastewater Treatment Plants | Q37336077 | ||
| Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant | Q37374188 | ||
| Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature | Q38007735 | ||
| Fluorinated alternatives to long-chain perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their potential precursors | Q38198673 | ||
| Global emission inventories for C4-C14 perfluoroalkyl carboxylic acid (PFCA) homologues from 1951 to 2030, Part I: production and emissions from quantifiable sources | Q38220533 | ||
| Perfluorooctane sulfonate: a review of human exposure, biomonitoring and the environmental forensics utility of its chirality and isomer distribution | Q38366490 | ||
| Persistence of perfluoroalkyl acid precursors in AFFF-impacted groundwater and soil | Q38395553 | ||
| Historical human exposure to perfluoroalkyl acids in the United States and Australia reconstructed from biomonitoring data using population-based pharmacokinetic modelling. | Q38619324 | ||
| Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community | Q38711850 | ||
| Discovery of 40 Classes of Per- and Polyfluoroalkyl Substances in Historical Aqueous Film-Forming Foams (AFFFs) and AFFF-Impacted Groundwater. | Q39014975 | ||
| Distribution of perfluorooctane sulfonate isomers and predicted risk of thyroid hormonal perturbation in drinking water | Q39024737 | ||
| Per- and Polyfluoroalkyl Substances (PFASs) in Food and Human Dietary Intake: A Review of the Recent Scientific Literature | Q39041060 | ||
| Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. | Q39360818 | ||
| Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid | Q39924495 | ||
| Human exposure to per- and polyfluoroalkyl substances (PFASs) via house dust in Korea: Implication to exposure pathway | Q39954507 | ||
| An ultra-sensitive method for the analysis of perfluorinated alkyl acids in drinking water using a column switching high-performance liquid chromatography tandem mass spectrometry | Q40276868 | ||
| The Nurses' Health Study | Q40382857 | ||
| Estimating human exposure to PFOS isomers and PFCA homologues: the relative importance of direct and indirect (precursor) exposure | Q41749955 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 67006 | |
| P577 | publication date | 2019-06-06 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Tap Water Contributions to Plasma Concentrations of Poly- and Perfluoroalkyl Substances (PFAS) in a Nationwide Prospective Cohort of U.S. Women | |
| P478 | volume | 127 |
| Q89836896 | Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial | cites work | P2860 |
Search more.